Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

Physicians' SNS App Medlinker Secures RMB 400 Mln Series C

Sina Tech, 12/06/17

Chengdu-based Yiyun Technology, operator of mobile social networking app for doctors Medlinker, recently announced completion of RMB 400 mln in Series C funding from Beijing-based data services firm Zhongdian Data Service's Zhongdian Health Fund, with participation by China Renaissance's New Economy Fund and prior-round investors including internet conglomerate Tencent (0700.HK) and Sequoia Capital.

Zhongdian Health Fund and Medlinker will share medical treatment data resources and will collaborate on clinical research organization (CRO) data analysis in the insurance and drug development domains as well as medical data disease treatment applications. They will also work together to pilot test province-level online health maintenance organization (HMO) programs, including development of new types of commercial insurance and family physician policies.

According to data from Medlinker, the platform currently has more than 430,000 certified physician users registered under their real names.

Editor's Note: The Medlinker app brings together doctors through a social networking site, offering features such as medical case sharing and doctors' circles (similar to WeChat groups). Physicians join Medlinker through an online registration, offline invitation system. For more information on Medlinker, please see Physicians SNS App 'Medlinker' Wins USD 40 Mln Series B Funding, MD 9/07/15 and Physicians SNS App 'Medlinker' to Open First Internet Hospital in Shandong, MD 1/13/17 issues.

Keywords: mobile SNS China Renaissance Group VC M&A mobile healthcare funding wireless Tencent Sequoia Capital Series C 0700.HK Medlinker Zhongdian Data


Please note, all fields are required.
None of your personal information will be shared with third parties.



The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports